Monoclonal antibody utilization characteristics in patients with multiple myeloma.
Ailawadhi S, Sher T, Azzouqa AG, Meghji Z, Jain T, Jani P, Ahmed S, Diehl N, Roy V, Shah V, Hodge D, Ailawadhi M, Alegria VR, Paulus A, Chanan-Khan A, Fonseca R.
Ailawadhi S, et al. Among authors: diehl n.
Anticancer Drugs. 2019 Sep;30(8):859-865. doi: 10.1097/CAD.0000000000000810.
Anticancer Drugs. 2019.
PMID: 31415286